Strategic Investment Advisors Amgen Inc Transaction History

Strategic Investment Advisors

$909 Million
Q3 2024

A detailed history of Strategic Investment Advisors transactions in Amgen Inc stock. As of the latest transaction made, Strategic Investment Advisors holds 10,270 shares of AMGN stock, worth $2.7 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares

10,270

Previous 9,351 9.83%

Holding current value

$2.7 Million

Previous $2.92 Million 13.28%

% of portfolio

0.36%

Previous 0.36%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$309.38 - $337.38 $284,320 - $310,052	919 Added 9.83%	10,270 $3.31 Million
Q2 2024 Jul 22, 2024	SELL	$262.75 - $319.31 $15,239 - $18,519	-58 Reduced 0.62%	9,351 $2.92 Million
Q1 2024 Apr 22, 2024	BUY	$268.87 - $324.56 $68,830 - $83,087	256 Added 2.8%	9,409 $2.68 Million
Q4 2023 Jan 10, 2024	SELL	$255.7 - $288.46 $79,267 - $89,422	-310 Reduced 3.28%	9,153 $2.64 Million
Q3 2023 Oct 24, 2023	BUY	$218.65 - $271.46 $104,077 - $129,214	476 Added 5.3%	9,463 $2.54 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $46,710 - $55,234	218 Added 2.49%	8,987 $2 Million
Q1 2023 Apr 27, 2023	BUY	$225.79 - $275.2 $96,638 - $117,785	428 Added 5.13%	8,769 $2.12 Million
Q4 2022 Jan 19, 2023	BUY	$229.03 - $291.01 $16,261 - $20,661	71 Added 0.86%	8,341 $0
Q3 2022 Oct 27, 2022	BUY	$224.46 - $253.15 $276,983 - $312,387	1,234 Added 17.54%	8,270 $1.86 Million
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $59,753 - $66,495	259 Added 3.82%	7,036 $1.71 Million
Q1 2022 Apr 28, 2022	SELL	$219.27 - $242.57 $11,402 - $12,613	-52 Reduced 0.76%	6,777 $1.64 Million
Q4 2021 Jan 26, 2022	SELL	$198.88 - $227.6 $118,333 - $135,422	-595 Reduced 8.01%	6,829 $1.54 Million
Q3 2021 Oct 19, 2021	BUY	$212.27 - $248.7 $1.58 Million - $1.85 Million	7,424 New	7,424 $1.58 Million
Q2 2021 Jul 22, 2021	SELL	$233.58 - $259.14 $1.58 Million - $1.75 Million	-6,761 Closed	0 $0
Q1 2021 Apr 14, 2021	SELL	$221.91 - $258.6 $977,957 - $1.14 Million	-4,407 Reduced 39.46%	6,761 $1.68 Million
Q4 2020 Jan 13, 2021	BUY	$216.38 - $257.67 $1.29 Million - $1.53 Million	5,940 Added 113.62%	11,168 $2.57 Million
Q3 2020 Oct 14, 2020	BUY	$234.65 - $260.95 $183,027 - $203,541	780 Added 17.54%	5,228 $1.32 Million
Q2 2020 Aug 04, 2020	BUY	$197.81 - $242.74 $30,264 - $37,139	153 Added 3.56%	4,448 $1.05 Million
Q1 2020 Apr 13, 2020	BUY	$182.24 - $241.7 $108,979 - $144,536	598 Added 16.18%	4,295 $871,000
Q4 2019 Jan 23, 2020	BUY	$189.21 - $243.2 $125,446 - $161,241	663 Added 21.85%	3,697 $891,000
Q3 2019 Oct 25, 2019	BUY	$174.11 - $208.62 $19,152 - $22,948	110 Added 3.76%	3,034 $587,000
Q2 2019 Jul 23, 2019	SELL	$166.7 - $195.41 $14,836 - $17,391	-89 Reduced 2.95%	2,924 $538,000
Q1 2019 Apr 30, 2019	BUY	$180.87 - $203.88 $92,062 - $103,774	509 Added 20.33%	3,013 $572,000
Q4 2018 Feb 08, 2019	BUY	$178.4 - $208.25 $446,713 - $521,458	2,504 New	2,504 $488,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Investment Advisors , based on Form 13F filings with the SEC.

News

Stay updated on Strategic Investment Advisors with notifications on news.

Account

Strategic Investment Advisors Amgen Inc Transaction History